Your browser doesn't support javascript.
loading
The spectrum of bone disease in 200 chronic hemodialysis patients: a correlation between clinical, biochemical and histologic findings
Duarte, Maria Eugenia Leite; Peixoto, Ana Lúcia Passos; Pacheco, Andréia da Silva; Peixoto, Angela Vieira; Rodriguez, Rodrigo Dezerto; Lugon, Jocemir Ronaldo; Cruz, Elisa Albuquerque Sampaio da.
  • Duarte, Maria Eugenia Leite; Universidade Federal Fluminense.
  • Peixoto, Ana Lúcia Passos; Universidade Federal Fluminense.
  • Pacheco, Andréia da Silva; Universidade Federal Fluminense.
  • Peixoto, Angela Vieira; Universidade Federal Fluminense.
  • Rodriguez, Rodrigo Dezerto; Universidade Federal Fluminense.
  • Lugon, Jocemir Ronaldo; Universidade Federal Fluminense.
  • Cruz, Elisa Albuquerque Sampaio da; Universidade Federal Fluminense.
São Paulo med. j ; 116(5): 1790-7, Sept.-Oct. 1998. graf
Artículo en Inglés | LILACS | ID: lil-225998
ABSTRACT

Introduction:

Renal osteodystrophy includes the complete range of mineral metabolism disordes that affect the skeleton in patients with chronic renal failure. Patients and

Methods:

200 patients with end-stage renal disease and on dialysis were investigated regarding the clinical, biochemical and histological findings of bone disease.

Results:

The spectrum of renal osteodystrophy consisted mainly of high turnover bone lesions (74.5 percent), including osteitis fibrosa in 57.5 percent. Patients with mild bone disease were on dialysis for shorter periods of time and were mostly asymptomatic. Patients with aluminum-related bone disease (16.5 percent) had the greatest aluminum exposure, either orally or parenterally, and together with patients with high turnover mixed disease, were the most symptomatic. Although on a non-regular basis, the vast majority of the patients (82.5 percent) had been receiving vitamin D. The incidence of adynamic bone disease was high (n=8) among parathyroidectomized patients (n=12). Significantly higher serum levels of alkaline phosphatase were observed in osteitis fibrosa.

Conclusions:

The use calcitriol and phosphate-binding agents on a non-regular basis seems to be the reason for the apparent reduced response to the treatment of secondary hyperparathyroidism. Alkaline phosphatase has been shown to be a fair marker for bone turnover in patients with osteitis fiborsa. The severity of the clinical manifestations of bone disease correlates with the histological features of bone lesion and to the time spent on dialysis.
Asunto(s)
Texto completo: Disponible Índice: LILACS (Américas) Asunto principal: Trastorno Mineral y Óseo Asociado a la Enfermedad Renal Crónica / Enfermedades Óseas / Diálisis Renal / Fallo Renal Crónico Tipo de estudio: Estudio diagnóstico Límite: Adolescente / Adulto / Niño / Femenino / Humanos / Masculino Idioma: Inglés Revista: São Paulo med. j Asunto de la revista: Cirurgia Geral / Ciˆncia / Ginecologia / Medicina / Medicina Interna / Obstetr¡cia / Pediatria / Sa£de Mental / Sa£de P£blica Año: 1998 Tipo del documento: Artículo País de afiliación: Brasil

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponible Índice: LILACS (Américas) Asunto principal: Trastorno Mineral y Óseo Asociado a la Enfermedad Renal Crónica / Enfermedades Óseas / Diálisis Renal / Fallo Renal Crónico Tipo de estudio: Estudio diagnóstico Límite: Adolescente / Adulto / Niño / Femenino / Humanos / Masculino Idioma: Inglés Revista: São Paulo med. j Asunto de la revista: Cirurgia Geral / Ciˆncia / Ginecologia / Medicina / Medicina Interna / Obstetr¡cia / Pediatria / Sa£de Mental / Sa£de P£blica Año: 1998 Tipo del documento: Artículo País de afiliación: Brasil